Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 8
504
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Oxepinamides L and M, two new oxepine-pyrimidinone-ketopiperazine type nonribosomal peptides from Aspergillus californicus

ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 2043-2048 | Received 21 Aug 2020, Accepted 27 Oct 2020, Published online: 09 Nov 2020
 

Abstract

A chemical investigation of Aspergillus californicus IBT 16748 led to the isolation of two new oxepine-pyrimidinone-ketopiperazine type nonribosomal peptides oxepinamides L (1) and M (2). Their structures were characterised by spectroscopic analysis including HRESIMS, 1D and 2D NMR. The absolute structure of 1 was assigned by ECD calculation. The antibacterial and cytotoxic properties of 1 were evaluated.

Graphical Abstract

Acknowledgments

The authors thank Dr. Kasper Enemark-Rasmussen and Associate Professor René Wugt Larsen from the Department of Chemistry at the Technical University of Denmark for acquiring NMR and IR data, respectively. Emil H. Kristiansen is acknowledged for his work on strain cultivation and chemical extraction.

Disclosure statement

The authors declare no potential conflicts of interest.

Additional information

Funding

This work was supported by the China Scholarship Council under grant number 201709110107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.